Mood disorders : When should we use repetitive transcranial magnetic stimulation?
Copyright © 2019 Elsevier Masson SAS. All rights reserved..
Repeated transcranial magnetic stimulation (rTMS) is still a recent treatment in psychiatry. This article aims at updating the clinicians'knowledge about rTMS in the treatment of mood disorders (uni and bipolar depressive disorders, manic/mixed states, suicidal risk, catatonia). It is intended for clinicians who are required to indicate and/or use rTMS in their current practice. rTMShas the highest level of evidence for the treatment of unipolar depression, provided that effective parameters are used, that is to say, for classical high frequency protocols: 20 to 30 sessions, 1000 pulses/session, 5 to 20Hz, and 110 % of the motor threshold. Low frequency protocol are also efficient and well tolerated. The duration of the efficacy varies with relapses rates around 50 % at one year. Pharmacological treatment generally remains associated. With regard to manic states, and mixed states the results are preliminary and limited to a possible reduction in symptoms. In the suicidal risk associated with mood disorders, the interest of rTMS is still to demonstrate, as well as in catatonia. The current place of the rTMS is no longer disputed in the curative treatment of major depressive disorder, preferentially used after one or two lines of antidepressants upstream. Further studies are needed to confirm preliminary positive findings in other aspects of mood disorders.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2019 |
|---|---|
| Erschienen: |
2019 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:48 |
|---|---|
| Enthalten in: |
Presse medicale (Paris, France : 1983) - 48(2019), 6 vom: 01. Juni, Seite 625-646 |
| Sprache: |
Französisch |
|---|
| Weiterer Titel: |
Troubles de l’humeur : quand recourir à la stimulation magnétique transcrânienne ? |
|---|
| Beteiligte Personen: |
Bulteau, Samuel [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Completed 02.07.2019 Date Revised 02.07.2019 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.lpm.2019.01.012 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM297730096 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM297730096 | ||
| 003 | DE-627 | ||
| 005 | 20231225092629.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2019 xx |||||o 00| ||fre c | ||
| 024 | 7 | |a 10.1016/j.lpm.2019.01.012 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n0992.xml |
| 035 | |a (DE-627)NLM297730096 | ||
| 035 | |a (NLM)31155435 | ||
| 035 | |a (PII)S0755-4982(19)30204-0 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a fre | ||
| 100 | 1 | |a Bulteau, Samuel |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Mood disorders |b When should we use repetitive transcranial magnetic stimulation? |
| 246 | 3 | 3 | |a Troubles de l’humeur : quand recourir à la stimulation magnétique transcrânienne ? |
| 264 | 1 | |c 2019 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 02.07.2019 | ||
| 500 | |a Date Revised 02.07.2019 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2019 Elsevier Masson SAS. All rights reserved. | ||
| 520 | |a Repeated transcranial magnetic stimulation (rTMS) is still a recent treatment in psychiatry. This article aims at updating the clinicians'knowledge about rTMS in the treatment of mood disorders (uni and bipolar depressive disorders, manic/mixed states, suicidal risk, catatonia). It is intended for clinicians who are required to indicate and/or use rTMS in their current practice. rTMShas the highest level of evidence for the treatment of unipolar depression, provided that effective parameters are used, that is to say, for classical high frequency protocols: 20 to 30 sessions, 1000 pulses/session, 5 to 20Hz, and 110 % of the motor threshold. Low frequency protocol are also efficient and well tolerated. The duration of the efficacy varies with relapses rates around 50 % at one year. Pharmacological treatment generally remains associated. With regard to manic states, and mixed states the results are preliminary and limited to a possible reduction in symptoms. In the suicidal risk associated with mood disorders, the interest of rTMS is still to demonstrate, as well as in catatonia. The current place of the rTMS is no longer disputed in the curative treatment of major depressive disorder, preferentially used after one or two lines of antidepressants upstream. Further studies are needed to confirm preliminary positive findings in other aspects of mood disorders | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 700 | 1 | |a Guirette, Charline |e verfasserin |4 aut | |
| 700 | 1 | |a Brunelin, Jérôme |e verfasserin |4 aut | |
| 700 | 1 | |a Poulet, Emmanuel |e verfasserin |4 aut | |
| 700 | 1 | |a Trojak, Benoît |e verfasserin |4 aut | |
| 700 | 1 | |a Richieri, Raphaëlle |e verfasserin |4 aut | |
| 700 | 1 | |a Szekely, David |e verfasserin |4 aut | |
| 700 | 1 | |a Bennabi, Djamila |e verfasserin |4 aut | |
| 700 | 1 | |a Yrondi, Antoine |e verfasserin |4 aut | |
| 700 | 1 | |a Rotharmel, Maud |e verfasserin |4 aut | |
| 700 | 1 | |a Bougerol, Thierry |e verfasserin |4 aut | |
| 700 | 1 | |a Dall'Igna, Gaëlle |e verfasserin |4 aut | |
| 700 | 1 | |a Attal, Jérôme |e verfasserin |4 aut | |
| 700 | 1 | |a Benadhira, René |e verfasserin |4 aut | |
| 700 | 1 | |a Bouaziz, Noomane |e verfasserin |4 aut | |
| 700 | 1 | |a Bubrovszky, Maxime |e verfasserin |4 aut | |
| 700 | 1 | |a Calvet, Benjamin |e verfasserin |4 aut | |
| 700 | 1 | |a Dollfus, Sonia |e verfasserin |4 aut | |
| 700 | 1 | |a Foucher, Jack |e verfasserin |4 aut | |
| 700 | 1 | |a Galvao, Filipe |e verfasserin |4 aut | |
| 700 | 1 | |a Gay, Aurélia |e verfasserin |4 aut | |
| 700 | 1 | |a Haesebaert, Frédéric |e verfasserin |4 aut | |
| 700 | 1 | |a Haffen, Emmanuel |e verfasserin |4 aut | |
| 700 | 1 | |a Jalenques, Isabelle |e verfasserin |4 aut | |
| 700 | 1 | |a Januel, Dominique |e verfasserin |4 aut | |
| 700 | 1 | |a Jardri, Renaud |e verfasserin |4 aut | |
| 700 | 1 | |a Millet, Bruno |e verfasserin |4 aut | |
| 700 | 1 | |a Nathou, Clément |e verfasserin |4 aut | |
| 700 | 1 | |a Nauczyciel, Cecilia |e verfasserin |4 aut | |
| 700 | 1 | |a Plaze, Marion |e verfasserin |4 aut | |
| 700 | 1 | |a Rachid, Fady |e verfasserin |4 aut | |
| 700 | 1 | |a Vanelle, Jean-Marie |e verfasserin |4 aut | |
| 700 | 1 | |a Sauvaget, Anne |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Presse medicale (Paris, France : 1983) |d 1986 |g 48(2019), 6 vom: 01. Juni, Seite 625-646 |w (DE-627)NLM012618160 |x 2213-0276 |7 nnns |
| 773 | 1 | 8 | |g volume:48 |g year:2019 |g number:6 |g day:01 |g month:06 |g pages:625-646 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.lpm.2019.01.012 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 48 |j 2019 |e 6 |b 01 |c 06 |h 625-646 | ||